Jommi, Claudio, and Roberto Ravasio. 2019. “The Value of Obinutuzumab for Untreated Advanced Follicular Lymphoma: An Assessment Based on Multicriteria Decision Analysis (MCDA)”. AboutOpen 6 (1):78-85. https://doi.org/10.33393/abtpn.2019.302.